AGIO - Agios Pharm - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

AGIO is currently covered by 7 analysts with an average price target of $53.53. This is a potential upside of $16.47 (44.44%) from yesterday's end of day stock price of $37.06.

Agios Pharm's activity chart (see below) currently has 132 price targets and 114 ratings on display. The stock rating distribution of AGIO is 31.82% HOLD and 68.18% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 64.61% with an average time for these price targets to be met of 132.15 days.

Highest price target for AGIO is $57, Lowest price target is $51, average price target is $52.43.

Most recent stock forecast was given by GREG HARRISON from BAML on 22-Jul-2025. First documented stock forecast 19-Aug-2013.

Currently out of the existing stock ratings of AGIO, 7 are a HOLD (31.82%), 15 are a BUY (68.18%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$51

$13.78 (37.02%)

$71

17 days ago
(22-Jul-2025)

6/9 (66.67%)

$11.34 (28.59%)

477

Buy

$57

$19.78 (53.14%)

$55

7 months 29 days ago
(10-Dec-2024)

5/6 (83.33%)

$10.98 (23.86%)

84

Buy

$51

$13.78 (37.02%)

9 months 29 days ago
(10-Oct-2024)

1/1 (100%)

$9.18 (21.95%)

27

Hold

$56

$18.78 (50.46%)

$61

10 months 12 days ago
(27-Sep-2024)

10/13 (76.92%)

$10.39 (22.78%)

223

Hold

$46

$8.78 (23.59%)

$30

1 years 1 months 26 days ago
(13-Jun-2024)

4/4 (100%)

$-0.77 (-1.65%)

169

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is AGIO (Agios Pharm) average time for price targets to be met?

On average it took 132.15 days on average for the stock forecasts to be realized with a an average price target met ratio 64.61

Which analyst has the current highest performing score on AGIO (Agios Pharm) with a proven track record?

JOHN NEWMAN

Which analyst has the most public recommendations on AGIO (Agios Pharm)?

John Newman works at CANACCORD and has 5 price targets and 4 ratings on AGIO

Which analyst is the currently most bullish on AGIO (Agios Pharm)?

Yatin Suneja with highest potential upside - $77.78

Which analyst is the currently most reserved on AGIO (Agios Pharm)?

Chad Messer with lowest potential downside - -$0

Agios Pharm in the News

Agios Pharmaceuticals (AGIO) Shares Cross Below 200 DMA

In trading on Thursday, shares of Agios Pharmaceuticals Inc (Symbol: AGIO) crossed below their 200 day moving average of $36.97, changing hands as low as $35.81 per share. Agios Pharmaceuticals Inc shares are currently trading down about 0.6% on the day. The chart below shows the one year performance of AGIO shares, versus its 200...

Agios Pharmaceuticals (AGIO) Reports Q2 Loss, Beats Revenue Estimates

Agios Pharmaceuticals (AGIO) came out with a quarterly loss of $1.93 per share versus the Zacks Consensus Estimate of a loss of $1.74. This compares to a loss of $1.69 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of -10.92%. A quarter ago, it...
Show more

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?